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Abstract 
 
ESAC, the EURL ECVAM Scientific Advisory Committee, advises EURL ECVAM on scientific 
issues. Its main role is to conduct independent peer review of validation studies of 
alternative test methods and to assess their scientific validity for a given purpose. The 
committee reviews the appropriateness of study design and management, the quality of 
results obtained and the plausibility of the conclusions drawn. ESAC peer reviews are 
formally initiated with a EURL ECVAM Request for ESAC Advice, which provides the 
necessary background for the peer-review and establishes its objectives, timelines and 
the questions to be addressed. The peer review is normally prepared by specialised ESAC 
Working Groups. These are typically composed of ESAC members and other external 
experts relevant to the test method under review. These experts may be nominated by 
ESAC, EURL ECVAM and partner organisations within the International Cooperation on 
Alternative Test Methods (ICATM). ESAC ultimately decides on the composition of these 
Working Groups. ESAC's advice to EURL ECVAM is formally provided as 'ESAC Opinions' 
and 'Working Group Reports' at the end of the peer review. ESAC may also issue 
Opinions on other scientific issues of relevance to the work and mission of EURL ECVAM 
but not directly related to a specific alternative test method.   
The ESAC Opinion expressed in this report relates to the peer-review of the SkinEthic™ 
Human Corneal Epithelium (HCE) Eye Irritation Test (EIT). 
 
 EUROPEAN COMMISSION 
DIRECTORATE-GENERAL 
JOINT RESEARCH CENTRE 
Directorate F - Health, Consumers and Reference Materials 
European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) 
 
Page | 2 
Ispra, 24 June 2016 
ESAC Opinion 
 
In April 2016, the EURL ECVAM Scientific Advisory Committee (ESAC) (Annex 1) received 
from EURL ECVAM a request for scientific advice on the L'Oréal-coordinated validation of 
the SkinEthic™ Human Corneal Epithelium (HCE) Eye Irritation Test (EIT) for serious eye 
damage/eye irritation testing (Annex 2). ESAC established a working group (WG) (Annex 
1) which delivered an ESAC WG report dated 6 June 2016 (Annex 3). 
The ESAC WG Eye Irritation was established to conduct a peer review of, and provide 
scientific advice on: 
1. A multi-laboratory trial involving 3 laboratories of the SkinEthic™ HCE Eye 
Irritation Test (EIT), a test method with a wide applicability domain for 
liquids (EITL: Eye Irritation Testing of Liquids) and solids (EITS: Eye 
Irritation Testing of Solids) and in particular to consider the relevance 
(biological/mechanistic relevance and predictive capacity; the latter in the 
context of an Integrated Approach to Testing and Assessment (IATA) 
(OECD, 2008)), and reliability (transferability; within and between 
laboratory reproducibility) of the test method.  
2. The usefulness of HPLC/UPLC-spectrophotometry as an alternative 
endpoint detection system to measure MTT-formazan, in particular for 
highly coloured chemicals interfering with the conventional endpoint 
measurement by OD-photometry when used specifically with SkinEthic™ 
HCE EIT.  
The analysis and conclusions of the ESAC WG were based primarily on the EURL ECVAM 
Test Submission Template (TST) and supporting documents supplied by L'Oréal, and 
supplementary information made available by L'Oréal during and after an 11 May 2016 
teleconference. 
Details of the validation study were previously published by Alépée et al. (2016a, b). 
The pre-defined study objectives were:  
 To formally validate the SkinEthic™ HCE EIT by a three laboratory ring trial study 
using an appropriate number and range of test chemicals and to obtain data to 
assess the relevance (predictive capacity) and reliability (reproducibility within 
and between laboratories) of the assay. 
 To produce data to facilitate its international acceptance in regulatory schemes for 
hazard assessment of liquid and solid chemicals to discriminate chemicals 
(substances and chemical mixtures) not requiring classification for serious eye 
damage/eye irritancy (No Category) from chemicals requiring classification and 
labelling (Category 1 and Category 2) according to the UN GHS Classification and 
Labelling of Chemicals (UN GHS. UN, 2015) and as implemented by the EU CLP 
regulation (EU CLP. EC, 2008a).  
o N.B. The test method was not designed, intended, or evaluated to 
differentiate between GHS Category 1 (irreversible effects) and 2A-B 
(reversible effects); or to test gases or aerosols. 
 To produce evidence and analysis to support the test method being incorporated 
into a tiered testing strategy (so-called Bottom-Up/Top-Down testing strategy, 
Page | 3 
Scott L. et al., 2010). The ultimate purpose of such a tiered testing strategy being 
to replace the traditional in vivo Draize eye test [Method B.5 of EC Regulation 
440/2008 (EC, 2008b) or OECD TG 405 (OECD, 2002)]. 
 
At its 42nd meeting, held on the 9th and 10th June 2016 at EURL ECVAM, Ispra, Italy, the 
non-Commission members of ESAC unanimously endorsed the following statement which 
was based on the ESAC WG report: 
ESAC concludes that, subject to the specific qualifications set out below, the study design 
was generally appropriate and robust, the acceptance criteria appropriate at the time, 
and that the study findings have provided the evidence and analysis required to satisfy 
the study objectives.  
While the SkinEthic™ HCE EIT was not developed to account for all mechanisms 
associated with eye irritation, the validation study demonstrated that this RhCE test 
method is able to correctly predict chemicals not requiring classification for serious eye 
damage/eye irritation independently of the types of ocular effects observed in vivo (i.e., 
corneal, iridal and conjunctival injuries). However, the available documentation does not 
allow an assessment of the test method’s performance with mixtures. 
The protocols for the testing of liquid and solid chemicals were found to be highly 
reproducible and to meet the predetermined acceptable performance values set by the 
EURL ECVAM/Cosmetics Europe Eye Irritation Validation Study (EIVS) Validation 
Management Group (VMG) for sensitivity, specificity and accuracy (Barroso et al., 2015; 
EURL ECVAM, 2016). 
ESAC believes the available documentation provides sufficient evidence and reasoned 
arguments in favour of this RhCE test method having the potential to be at least as 
relevant and reliable as the currently validated in vitro methods for the identification of 
non-irritants [OECD TGs 437 (OECD, 2013a), 438 (OECD, 2013b), 491 (OECD, 2015a), 
and 492 (OECD, 2015b)],  when combined with other alternative methods within future 
(tiered) testing strategies to replace the Draize eye test (Scott et al., 2010). 
The SkinEthic™ HCE EIT validation study was generally well designed and conducted, 
allowing ESAC to offer an informed opinion about the performance of the test method. 
ESAC believes that the overall relevance and reliability of the test method has been 
satisfactorily demonstrated with a view to it being considered for regulatory use in a 
tiered assessment strategy. The test method could be applied as a first step in Bottom-
Up discrimination of 'non-irritants' (GHS No Category) or as a confirmatory last step in a 
Top-Down approach, where the priority is to first discriminate chemicals inducing serious 
eye damage (GHS Category 1). However, the method is not intended to differentiate 
Category 1 from Category 2 on its own. 
 
 
HPLC/UPLC-spectrophotometry 
The study results tend to confirm the findings of the EIVS study that suitably qualified 
HPLC/UPLC-spectrophotometry analytical systems can be used to quantify precipitated 
MTT-formazan as an alternative endpoint detection system in particular for highly 
coloured chemicals interfering with the conventional endpoint measurement of MTT-
formazan by OD-photometry.   
Page | 4 
Table 1. Eye Irritation Validation Study (EIVS) target values and values obtained by the 
three laboratories participating in the ring test for within laboratory reproducibility (WLR), 
between laboratory reproducibility (BLR), sensitivity, specificity and accuracy. Two-sided 
95 %-Confidence Intervals (CIs) are also provided. 
 
 EIVS Target Values 
EITL EITS 
    
WLR (Lab1) ≥ 85 % 95.0 % 
95 %-CI: 86.3 % - 98.3 % 
96.7 % 
95 %-CI: 88.6 % - 99.1 % 
WLR (Lab2) ≥ 85 % 88.3 % 
95 %-CI: 77.8 % - 94.2 % 
95.0 % 
95 %-CI: 86.3 % - 98.3 % 
 
WLR (Lab 3) ≥ 85 % 93.3 % 
95 %-CI: 84.1 % - 97.4 % 
95.0 % 
95 %-CI: 86.3 % - 98.3 % 
    
    
BLR (Lab 1 v Lab 2)  93.3 % 96.7 % 
BLR (Lab 1 v Lab 3)  95.0 % 96.7 % 
BLR (Lab 2 v Lab 3)  98.3 % 100 % 
BLR (Cumulative) ≥ 80 % 93.3 % 
95 %-CI: 84.1 % - 97.4 % 
96.7 % 
95 %-CI: 88.6 % - 99.1 % 
    
Sensitivity (Lab 1) ≥ 90 % 100 % 92.2 % 
Sensitivity (Lab 2) ≥ 90 % 97.9 % 92.2 % 
Sensitivity (Lab 3) ≥ 90 % 96.9 % 92.2 % 
Sensitivity (Cumulative) ≥ 90 % 98.3 % 92.2 % 
Sensitivity  
(Bootstrap Resampling) 
≥ 90 % 98.2 % 
95 %-CI  93.8 % - 100 % 
91.9 % 
95 %-CI  90.0 % - 93.3 % 
    
Specificity (Lab 1) ≥ 60 % 65.5 % 75.6 % 
Specificity (Lab 2) ≥ 60 % 72.6 % 78.9 % 
Specificity (Lab 3) ≥ 60 % 70.2 % 75.3 % 
Specificity (Cumulative) ≥ 60 % 69.4 % 76.6 % 
Specificity  
(Bootstrap Resampling) 
≥ 60 % 69.4 % 
95 %-CI  60.7 % - 75.0 % 
76.6 % 
95 %-CI  73.3 % - 80.0 % 
    
Accuracy (Lab 1) ≥ 75 % 83.9 % 83.9 % 
Accuracy (Lab 2) ≥ 75 % 86.1 % 85.6 % 
Accuracy (Lab 3) ≥ 75 % 84.4 % 83.3 % 
Accuracy (Cumulative) ≥ 75 % 84.8 % 84.4 % 
Accuracy  
(Bootstrap Resampling) 
≥ 75 % 84.8 % 
95 %-CI  80.8 %- 88.3 % 
84.3 % 
95 %-CI  81.7 % - 86.7 % 
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1. TYPE OF REQUEST 
Request Type Identify request ("YES") 
R1 ESAC Peer Review  
of a Prevalidation Study or Validation Study 
YES, external validation study  
(i.e. not coordinated by EURL ECVAM) 
If R1)applies please specify further: 
►Prevalidation Study NO 
►Prospective Validation Study YES  
Background 
In December 2008, two reconstructed human eye tissue 
models for in vitro assay of eye irritation potential, 
EpiOcular™ Eye Irritation Test (EIT) and SkinEthic™ Human 
Corneal Epithelium (HCE), were sponsored for validation as 
alternatives to the traditional in vivo standard practice with 
rabbits (Draize test). The eye irritation validation study 
(EIVS) was conceived as a ring trial of comparative 
performance among six participant laboratories (three for 
each test method), testing selected chemicals to evaluate 
reliability (reproducibility within and between laboratories 
of results obtained in vitro) and relevance (predictive 
capacity of effects documented in vivo).  
Neither test method was able to comply fully with the 
acceptance criteria set by the validation management group 
(VMG). Therefore, further optimisation was recommended.  
With minor refinement to the EpiOcular™ EIT protocol, the 
method was successfully validated in 2013.  
The SkinEthic™ HCE protocol was subject to more 
comprehensive revision, followed by another validation ring 
trial (three laboratories) completed in 2015. 
In November 2015 the revised SkinEthic™ HCE test method 
was submitted for assessment by EURL ECVAM and formal 
peer-review by ESAC. 
►Retrospective Validation Study NO 
►Validation Study based on Performance 
Standards 
NO 
R2 Scientific Advice on a test method submitted to 
EURL ECVAM for validation  
(e.g. the test method's biological relevance etc.) 
NO 
R3 Other Scientific Advice  
(e.g. on test methods, their use; on technical issues such as cell 
culturing, stem cells, definition of performance standards etc.) 
NO 
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2. TITLE OF STUDY OR PROJECT FOR WHICH SCIENTIFIC ADVICE OF THE 
ESAC IS REQUESTED 
L’Oréal-coordinated validation of the in vitro SkinEthic™ Human Corneal Epithelium (HCE) Eye 
Irritation Test (EIT) 
 
 
3. BRIEF DESCRIPTION OF THE STUDY OR PROJECT 
1) Serious eye damage/eye irritation and regulatory tests 
Eye irritation is the result of reversible anterior surface tissue trauma, causing degeneration of vision. 
Serious eye damage is not fully reversible within 21 days of exposure (UN, 2013). Traditionally, eye 
irritation has been determined by the in vivo rabbit Draize eye test (OECD Test Guideline 405, 2012).  
Validated in vitro alternative methods include: 
-  organotypic assays: Bovine Corneal Opacity and Permeability test (OECD updated Test 
Guideline 437, 2013) and Isolated Chicken Eye test (OECD updated Test Guideline 438, 2013). 
-  cell-based methods: Fluorescein Leakage assay (OECD Test Guideline 460, 2012), Cytosensor 
Microphysiometer assay (OECD draft Test Guideline, 2012) and Short Time Exposure assay 
(OECD Test Guideline 491, 2015). 
-  reconstructed human cornea-like epithelium (RhCE) test: EpiOcular™ EIT (OECD Test Guideline 492, 
2015). 
 
 2) SkinEthic™ HCE EIT purpose 
At present, no single in vitro method can fully replace the in vivo Draize eye test for assessment of 
serious eye damage/eye irritation. However, tiered combination of alternatives (so-called Top-
Down/Bottom-Up approach) can reduce/replace reliance on in vivo procedures (Scott et al., 2010; 
OECD draft Guidance, 2015). Top-Down differentiates chemicals inducing serious eye damage (GHS 
category 1) as priority, while Bottom-Up first discriminates 'non-irritants' (GHS no category). 
The SkinEthic™ HCE EIT method is intended for inclusion in a Top-Down/Bottom-Up assessment 
strategy, particularly relevant for industrial chemicals or chemicals used in human exposure products, 
such as cosmetics ingredients which are banned from animal testing. The method is therefore 
required as an alternative, also effectively reducing the need for animal studies by their partial 
replacement. The SkinEthic™ HCE is the second RhCE test method that is validated following 
EpiOcular™ EIT. It is however important to have at least two of these methods validated and 
accepted by regulatory authorities in order to guarantee the widespread availability of this 
technology and avoid potential market monopolies. 
In a tiered assessment strategy, the SkinEthic™ HCE EIT method is applicable as a first step in Bottom-
Up discrimination of 'non-irritants' or as a confirmatory last step in a Top Down approach. However, 
the method is not intended to differentiate category 1 from 2 on its own. 
 
3) SkinEthic™ HCE EIT principle 
The test method addresses eye irritation caused by topical exposure to chemicals, manifested in vivo 
as local inflammation and/or opacity, resulting mechanistically from cell damage (cytotoxicity). 
The in vitro test system uses immortalized human corneal epithelial cells, cultured to form a 
Reconstructed human Cornea-like Epithelium (RhCE), i.e. a three-dimensional tissue similar to the 
human corneal epithelium. The test method was developed to model in vivo topical exposure, with 
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prediction of positive or negative irritation response from cell viability assay. Tissue viability is 
determined quantitatively as a percentage, relative to a negative control (100% viable) by 
standardised MTT assay (photometric measurement of purple formazan production from enzymatic 
reduction of the vital dye MTT). Tissues treated with eye irritants show a decrease in viability relative 
to the negative control, with discrimination of positive or negative GHS classification defined by an 
optimised viability threshold percentage (prediction model). 
The revised SkinEthic™ HCE test submission is complete with comprehensive protocols (SOPs) for eye 
irritation testing of liquids (EITL) and solids (EITS) as used in the validation study (Attachments 1a & 
1b, respectively) and as intended for test method users (Attachments 1c & 1d, respectively). 
Critical elements of the SOPs include: 
-  test system description (Human Corneal Epithelium tissue model, with quality control). 
-  TT: test treatment (application, exposure, incubation, MTT-formazan extraction). 
-  viability determination (MTT formazan assay: OD measurement, HPLC). 
- prediction model: EITL (60% threshold) and EITS (50% threshold). 
Acceptance criteria (for qualified test, qualified run, and complete test): 
-  NgC: negative control (PBS): 1.4 ≤ OD ≤ 2.5 (mean of 2 replicate tissues). 
-  PC: positive control (methyl acetate): viability ≤  30% (mean of 2 tissue replicates). 
-  viability difference between run replicates ≤ 20 (NgC, PC, TT). 
 
4) SkinEthic™ HCE EIT optimisation 
The test method was developed by L’Oréal, with prediction model optimization using 125 chemicals, 
including 71 liquids and 54 solids (Attachment 2). 
A principal criterion for selection of test chemicals was availability of supporting complete and quality 
assured in vivo Draize eye irritation data. The selection was limited to commercially available 
chemicals.  
The chemicals, incorporating 44/125 (35%) previously selected for the original ring trial eye irritation 
validation study (EIVS) provided a range of properties, including:  
-  Chemical class (functional group): soap/surfactant, organics (neutral, acid and base) and 
inorganic base. 
-   Several colour interfering chemicals, MTT reducers and MTT reducing coloured chemicals. 
-  GHS classification: 49% not classified (NC) and 51% classified (C) (divided as 53% Category 1 
and 47% Category 2. 
As distribution of physical state and GHS classification category, the 125 chemicals covered: 34 
Category 1 (19 liquids and 15 solids), 21 Category 2A (16 liquids and 5 solids), 9 Category 2B (4 liquids 
and 5 solids) and 61 No Category (32 liquids and 29 solids). 
The complement of chemicals used for development and optimization represents a significant and 
balanced set. 
 
5) SkinEthic™ HCE EIT training and transfer 
Transferability of the method was demonstrated using 18 chemicals (9 solids / 9 liquids) including 
strong colorants and MTT reducers known to cause interference, aiming to cover all experimental 
eventualities. 
Two training days are required for a naïve laboratory, including practical application and data 
evaluation. Actual transfer of the method was arranged over two weeks, testing the 18 chemicals in 
replicate independent series to allow evaluation of: 
-  adherence to acceptance criteria. 
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-  single and dual operator comparison.  
-  predictive concordance.  
Results demonstrated accurate and reproducible implementation. 
The training exercise has been described in full, with detailed method SOPs (Attachments 4a and 4b) 
and assessment reports (Attachments 5a, 5b, 5c, and 5d). 
SOP implementation (transfer) by the naïve laboratories has also been reported in full (Attachments 
6a and 6b) indicating the method is both robust and transferable. 
 
6) SkinEthic™ HCE EIT validation 
The ring trial validation study (EITL and EITS) for evaluation of within/between laboratory 
reproducibility (WLR/BLR) and predictive capacity (PC) included 120 chemicals (60 liquids, 60 solids) 
tested in three laboratories (L'Oréal, Charles River, Vito) with an additional 80 chemicals (45 liquids, 
35 solids) tested by L'Oréal (lead laboratory). 
The chemical selection (Attachment 2) again covered a range of properties: 
-  the full range of in vivo eye irritation GHS Categories (1, 2A, 2B, or No Category). 
-  the in vivo determinants of classification (cornea opacity, iritis, conjunctiva redness, chemosis, 
reversibility/persistence). 
-  wide representation of organic functional groups. 
-  known chemical structures.  
-  coloured and/or direct MTT reducers. 
-  availability through laboratory retail supply, at reasonable cost. 
The processing and analysis of all data from the three laboratories in the ring trial was contracted to 
an independent consultant statistician who has compiled 2 comprehensive reports, respective of the 
liquid and solid protocols (Attachments 8a and 8b). The reports are clear and concise, uniformly 
applying the acceptance criteria and prediction model to determine within laboratory reproducibility 
(WLR) between laboratory reproducibility (BLR) and predictive capacity (PC). 
The test submitter (L'Oréal) has also compiled all data used for method evaluation, provided as 
attachments in pdf and xls formats: 
-  Attachment 3a: Data used for relevance and reliability assessment (EITL and EITS). 
-  Attachment 3b: EITL: WLR assessment: 60 ring trial chemicals, 3 labs (L'Oreal, VITO, CRL). 
-  Attachment 3c: EITL: WLR assessment: 45 additional chemicals, 1 lab (L'Oreal). 
-  Attachment 3d: EITS: WLR assessment: 60 ring trial chemicals, 3 labs (L'Oreal, VITO, CRL). 
-  Attachment 3e: EITS: WLR assessment: 35 additional chemicals, 1 lab (L'Oreal). 
-  Attachment 7a: EITL: BLR assessment: 60 ring trial chemicals, 3 labs (L'Oreal, VITO, CRL). 
-  Attachment 7b: EITS: BLR assessment: 60 ring trial chemicals, 3 labs (L'Oreal, VITO, CRL). 
-  Attachment 9: EIT: Predictive capacity (PC) assessment. 
 
7) SkinEthic™ HCE EIT results 
Within Laboratory Reproducibility (WLR) 
WLR (concordance of predicted classification) based on the set of 120 chemicals, was reported as 
follows: 
-  CRL:  91.7% (EITL 88.3% and EITS 95.0%).  
-  VITO:  94.2% (EITL 93.3% and EITS 95.0%).  
-  L'Oreal:  95.8% (EITL 95.0% and EITS 96.7%).  
WLR for the extended set of 200 chemicals (tested by L’Oreal only) was: 
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-  95.0% (EITL 93.3% and EITS 96.8%).  
The test submission report concluded that the SkinEthic™ HCE EIT method (liquids/solids) has been 
shown to exceed the minimum requirement for WLR of 85% set by the validation management group 
(VMG) of EIVS. The WLR is also comparable to that obtained previously for a similar method, 
EpiOcular™ EIT. 
 
Between Laboratory Reproducibility (BLR) 
Fifty six of the 60 liquid chemicals were consistently classified (NC/C) by the three laboratories 
resulting in a BLR (concordance of predicted classification) of 93.3% (95% CI: 84.1% - 97.4%). BLR 
based on pair-wise comparison, was reported as follows: 
-  L'Oreal versus CRL:  93.3% (56/60 chemicals).  
-  L'Oreal versus VITO:  95.0% (57/60 chemicals).  
- CRL versus VITO:  98.3% (59/60 chemicals). 
Fifty eight of the 60 solid chemicals were consistently classified (NC/C) by the three laboratories 
resulting in a BLR (concordance of predicted classification) of 96.7% (95% CI: 88.6% - 99.1%). BLR 
based on pair-wise comparison, was reported as follows: 
-  L'Oreal versus CRL and L'Oreal versus VITO: 96.7% (58/60 chemicals).  
-  CRL versus VITO:  100%. 
The test submission report concluded overall BLR for the SkinEthic™ HCE EIT method, based on the 
set of 120 chemicals, was 95.0% (EITL 93.3% and EITS 96.7%) exceeding the defined minimum 
requirement of 80% set by the VMG of EIVS. 
For comparison, the test submission reported BLR from the previous ring trial validation of the similar 
test method EpiOcular™ EIT was 94.4% for liquids and 92.0% for solids. 
 
Predictive Capacity (PC) 
PC (ring trial) was evaluated by comparing in vitro viability with respect to prediction model (all runs, 
per laboratory and cumulatively) with documented in vivo classifications according to GHS. 
The statistics report summarises the frequency distribution of true versus false predictions, 
respective of irritant classification (C) and non-irritant classification (NC). From these frequencies are 
calculated the sensitivity (rate of correct prediction for C, with false negatives), the specificity (rate of 
correct prediction for NC, with false positives) and overall accuracy (rate of correct prediction, C or 
NC) expressed as percentages: 
Liquids protocol (EITL) predictive capacity (ring trial): 
 in vivo  Cumulative  L’Oréal CRL  VITO 
 C  NC  C  NC  C  NC  C  NC 
 Classified  283  5  96  0  94  2  93  3 
 No Category  77  175  29  55  23  61  25  59 
 Total  540  180  180  180 
   
 Sensitivity (%)  98.3  100  97.9  96.9 
 False Negatives (%)  1.7  0  2.1  3.1 
 Specificity (%)  69.4  65.5  72.6  70.2 
 False Positives (%)  30.6  34.5  27.4  29.8 
 Accuracy (%)  84.8  83.9  86.1  84.4 
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From statistical bootstrap resampling (which estimates uncertainty in predictive capacity, as 95% CI) 
(10,000 re-samples at n=1 for the 60 chemicals) the statistics report indicates overall predictive 
capacity for the liquids protocol (EITL): 
 Parameter  Estimate  95% CI 
 Sensitivity (%)  98.2  93.8; 100 
 Specificity (%)  69.4  60.7; 75.0 
 Accuracy (%)  84.8  80.0; 88.3 
 
Solids protocol (EITS) predictive capacity (ring trial): 
 in vivo  Cumulative  L’Oréal  CRL  VITO 
 C  NC  C  NC  C  NC  C  NC 
 Classified  249  21  83  7  83  7  83  7 
 No Category  63  206  22  68  19  71  22  67 
 Total  539  180  180  179 
 
 Sensitivity (%)  92.2  92.2  92.2  92.2 
 False Negatives (%)  7.8  7.8  7.8  7.8 
 Specificity (%)  76.6  75.6  78.9  75.3 
 False Positives (%)  23.4  24.4  21.1  24.7 
 Accuracy (%)  84.4  83.9  85.6  83.3 
From statistical bootstrap resampling (which estimates uncertainty in predictive capacity, as 95% CI) 
(10,000 re-samples at n=1 for the 60 chemicals) the statistics report indicates predictive capacity for 
the solids protocol (EITS): 
 Parameter  Estimate  95% CI 
 Sensitivity (%)  91.9  90.0; 93.3 
 Specificity (%)  76.6  73.3; 80.0 
 Accuracy (%)  84.3  81.7; 86.7 
The test submission also reports sensitivity, specificity and accuracy for the extended set of chemicals 
(including 45 additional liquids and 35 additional solids tested by the lead laboratory only) quoting 
similar figures. 
 
8) HPLC spectrophotometry 
The MTT-reduction assay for tissue viability, relevant to all in vitro test methods based on 
Reconstructed human Tissues (RhT) is limited by interference with coloured chemicals.  
The test method R&D has overcome this limitation using High/Ultra High Performance Liquid 
Chromatography Performance (HPLC-UPLC)-spectrophotometry for endpoint detection of formazan. 
The HPLC-UPLC method has been shown to be highly reproducible (BLR) between different 
laboratories.  
Based on this, the test submission report concludes that HPLC/UPLC is relevant to all in vitro RhT test 
methods irrespective of the test system and test method and can be applied to any of the other RhT 
test systems within the relevant OECD Test Guidelines. Indeed, the HPLC/UPLC-spectrophotometry 
technique has already been implemented in OECD TGs 431 (in vitro skin corrosion based on RhE), 439 
(in vitro skin irritation based on RhE) and 492 (in vitro serious eye damage/eye irritation based on 
RhCE). 
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4. OBJECTIVES, QUESTIONS, TIMELINES 
4.1  OBJECTIVE 
Objective 
Why does EURL 
ECVAM require 
advice on the 
current issue? 
EURL ECVAM requests an ESAC opinion on the reliability (reproducibility within and 
between laboratories of results obtained in vitro) and relevance (predictive capacity of 
effects documented in vivo) of the SkinEthic™ Human Corneal Epithelium (HCE) Eye 
Irritation Test (EIT) for prediction of eye irritation potential of chemicals. The 
opinion of ESAC should support EURL ECVAM with respect to the development of 
an EURL ECVAM recommendation on the Reconstructed human Cornea-like 
Epithelium (RhCE) assays for serious eye damage/eye irritation testing outlining (1) 
the scientific basis of the assays, (2) their overall performance (transferability, 
reproducibility and predictive capacity) as assessed during the validation studies 
and based on other (e.g. published) information, (3) their applicability and 
limitations, and 4) their proposed use. 
ESAC's advice should enable EURL ECVAM to conclude, within its EURL ECVAM 
Recommendation, on the potential adequacy of the SkinEthic™ HCE EIT for routine 
testing of serious eye damage/eye irritation for regulatory purposes. 
 
 
4.2  QUESTION(S) TO BE ADDRESSED 
Questions 
What are the 
questions and 
issues that should 
be addressed in 
view of achieving 
the objective of 
the advice? 
The ESAC peer review of the SkinEthic™ HCE EIT should address the following 
aspects: 
(1) Scientific basis in relation to serious eye damage/eye irritation. 
(2) Clarity of the test definition, including: 
- purpose and need of the test method. 
- biological/mechanistic relevance in relation to the test system used and the 
endpoint measured. 
- protocol clarity and completeness. 
- clarity and adequacy of the prediction model and its development. 
(3) Clarity of the definition of the study objective(s). 
(4) Appropriateness of the study design and execution considering the study 
objective(s), including: 
- number and selection criteria for test chemicals (e.g., range of documented 
effects in vivo, etc.). 
- quality assurance of reference data (in vivo) for predictive capacity 
assessment. 
- number of participating laboratories. 
- number of replicates, number of repetitions, rules for retesting and handling 
of deviations. 
(5) Study management and conduct. 
(6) Results compilation and statistical analyses reporting. 
- appropriateness of calculation of WLR and BLR on the basis of the generated 
data. 
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- appropriateness of calculation of Predictive Capacity on the basis of the 
generated data. 
- appropriateness of identification of limitations/applicability domain on the 
basis of the generated data. 
(7) Transferability and reproducibility (WLR/BLR). 
(8) Predictive capacity for distinguishing chemicals not requiring classification 
from chemicals requiring classification as Category 1 (serious eye damage) or 
Category 2 (eye irritation) and relevance to a tiered (Top-Down/Bottom-Up) 
testing strategy. 
(9) Applicability and any known limitations, assessed from the selection of the 
test chemicals (range of molecular class and physical properties) and analyses 
of possible reasons for misclassifications. 
(10) Possible gaps, if any, between study design and study conclusions. 
(11) Whether the information provided in the submission is sufficient to 
substantiate the proposed use of the test method within a Bottom-Up/Top-
Down testing strategy. 
(12) Usefulness and applicability of HPLC/UPLC-spectrophotometry as an 
alternative endpoint detection system to standard photometry in SkinEthic™ 
HCE EIT. 
(13) What additional work, if necessary, should be undertaken in future to 
further characterise the test method and its proposed use. 
ESAC's advice should conclude on the regulatory applicability of the SkinEthic™ 
HCE EIT (i.e., for implementation as an EU test method and OECD Test Guideline). 
 
4.3  TIMELINES 
Timelines 
concerning this 
request 
When does EURL 
ECVAM require 
the advice? 
Timeline Indication 
Finalised ESAC Opinion required by: June 2016 
Request to be presented to ESAC by 
written procedure (e.g. due to 
urgency) prior to the next ESAC 
YES 
Request to be presented to ESAC at 
ESAC plenary meeting 
NO 
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5.  EURL ECVAM PROPOSALS ON HOW TO ADDRESS THE REQUEST WITHIN 
ESAC 
5.1  EURL ECVAM PROPOSAL REGARDING REQUEST-RELATED STRUCTURES REQUIRED 
Specific 
structures 
required within 
ESAC to address 
the request 
Does the advice 
require an ESAC 
working group, an 
ESAC rapporteur 
etc.? 
Structure(s) required Required according to EURL ECVAM? 
(YES/NO) 
S1 ESAC Rapporteur NO 
S2 ESAC Working Group 
ESAC members 
- José M. Navas (Chair) 
- Kristina Kejlová 
- Annete Kopp-Schneider 
- Renate Kraetke 
- Jon Richmond 
ICATM nominations 
- Dave Allen (NICEATM/ICCVAM) 
- Kyung-Min Lim (College of Pharmacy, 
Ewha Womans University; nominated by 
KoCVAM) 
S3 Invited Experts NO 
Ad S3: If yes – list names and 
affiliations of suggested 
experts to be invited and 
specify whether these are 
member of the EEP 
 
If other than above (S1-S3):   
 
5.2  DELIVERABLES AS PROPOSED BY EURL ECVAM 
Deliverables 
What deliverables 
(other than the 
ESAC opinion) are 
required for 
addressing the 
request? 
Title of deliverable other 
than ESAC opinion 
Required? (YES/NO) 
D1 ESAC Rapporteur Report 
and draft opinion  
NO 
D2 ESAC Peer Review Report 
and draft opinion 
YES 
If other than above (D1-D2):  
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6. LIST OF DOCUMENTS TO BE MADE AVAILABLE TO THE ESAC 
 
Count Description of document Already 
available? 
(YES/NO) 
File name 
1 SkinEthic™ HCE test submission (TST) YES TST SkinEthic HCE EIT_Amended.pdf 
2 
EURL ECVAM Assessment Report on the 
SkinEthic™ HCE test submission 
YES 
SkinEthic_HCE_assessment_report_2016-
05-09_final.pdf 
3 
Protocol of the SkinEthic™ HCE EITL 
(Liquid) 
YES Attachment 1a.pdf 
4 Protocol of the SkinEthic™ HCE EITS (Solid) YES Attachment 1b.pdf 
5 
SkinEthic™ HCE EITL (Liquid) DB-ALM 
protocol 
YES Attachment 1c.pdf 
6 
SkinEthic™ HCE EITS (Solid) DB-ALM 
protocol 
YES Attachment 1d.pdf 
7 
SkinEthic™ HCE EIT - List of test items 
including their CAS number and basic 
physical/chemical properties for 
optimisation/transfer/WLR/BLR/Predictive 
capacity  
YES Attachment 2.pdf 
8 
SkinEthic™ HCE EIT - Data used for 
relevance and reliability assessment (EITL 
and EITS) 
YES Attachment 3a.pdf 
9 
SkinEthic™ HCE EITL - WLR assessment  
(60 chemicals – 3 labs) 
YES Attachment 3b.pdf 
10 
SkinEthic™ HCE EITL - WLR assessment  
(45 additional chemicals – 1 lab) 
YES Attachment 3c.pdf 
11 
SkinEthic™ HCE EITS - WLR assessment  
(60 chemicals – 3 labs) 
YES Attachment 3d.pdf 
12 
SkinEthic™ HCE EITS - WLR assessment  
(35 additional chemicals – 1 lab) 
YES Attachment 3e.pdf 
13 
Training protocol of the SkinEthic™ HCE 
EITL (Liquids) 
YES Attachment 4a.pdf 
14 
Training protocol of the SkinEthic™ HCE 
EITS (Solids) 
YES Attachment 4b.pdf 
15 
Training report of the SkinEthic™ HCE EITL  
(Liquids) - VITO 
YES Attachment 5a.pdf 
16 
Training report of the SkinEthic™ HCE EITL  
(Liquids) - CRL 
YES Attachment 5b.pdf 
17 
Training report of the SkinEthic™ HCE EITS  
(Solids) - VITO 
YES Attachment 5c.pdf 
18 
Training report of the SkinEthic™ HCE EITS  
(Solids) – CRL 
YES Attachment 5d.pdf 
19 
Transfer report of the SkinEthic™ HCE EITL  
(Liquids) – VITO & CRL 
YES Attachment 6a.pdf 
20 
Transfer report of the SkinEthic™ HCE EITS  
(Solids) – VITO & CRL 
YES Attachment 6b.pdf 
21 
SkinEthic™ HCE EITL - BLR assessment  
(60 chemicals – 3 labs) 
YES Attachment 7a.pdf 
22 
SkinEthic™ HCE EITS - BLR assessment  
(60 chemicals – 3 labs) 
YES Attachment 7b.pdf 
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23 
Statistical analysis and reporting of the 
SkinEthic™ HCE EITL (Liquids) 
YES Attachment 8a_Revised.pdf 
24 
Statistical analysis and reporting of the 
SkinEthic™ HCE EITS (Solids) 
YES Attachment 8b.pdf 
25 
SkinEthic™ HCE EIT – Predictive capacity 
assessment  
YES Attachment 9.pdf 
26 
Project plan of the SkinEthic™ HCE EITL 
(Liquids) 
YES Attachment 10a.pdf 
27 
Project plan of the SkinEthic™ HCE EITS 
(Solids) 
YES Attachment 10b.pdf 
28 
SkinEthic™ HCE EIT - HPLC/UPLC-
spectrophotometry (24 chemicals – 1 lab) 
YES Attachment 11.pdf 
29 Publication on the validation of EITL YES 
Alépée et al. 2016 - SkinEthic HCE 
liquids.pdf 
30 Publication on the validation of EITS YES 
Alépée et al. 2016 - SkinEthic HCE 
solids.pdf 
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7. TERMS OF REFERENCE OF THE ESAC WORKING GROUP 
7.1 ESTABLISHMENT OF THE ESAC WORKING GROUP 
The ESAC unanimously agreed by written procedure on the 18th of February 2016 on the composition 
of a new ESAC Working Group for the review of test methods in the area of serious eye damage/eye 
irritation. 
 
7.2 TITLE OF THE ESAC WORKING GROUP 
Full title:  
ESAC Working Group on Eye Irritation Test Methods 
 
Abbreviated title:  
ESAC WG Eye Irritation 
 
7.3 MANDATE OF THE ESAC WORKING GROUP 
The ESAC WG is requested to conduct a scientific review of the l'Oréal-coordinated validation study 
concerning the SkinEthic™ HCE EIT. The review needs to address the questions put forward to ESAC 
by EURL ECVAM under section 4.2 of the current request. 
The review should focus on the appropriateness of design and conduct of the study in view of the 
study objective and should provide an appraisal to which extent the conclusions of the test submitter 
are substantiated by the information generated during the study and how the information generated 
relates to the scientific background available. 
 
7.4 DELIVERABLES OF THE ESAC WORKING GROUP 
The ESAC WG is requested to deliver to the chair of the ESAC and the ESAC Coordinator a detailed 
ESAC Working Group Report outlining its analyses and conclusions and a draft ESAC Opinion. A 
template has been appended (Appendix 1) intended to facilitate the drafting of the WG report. 
The conclusions drawn in the report should be based preferably on consensus. If no consensus can 
be achieved, the report should clearly outline the differences in the appraisals and provide 
appropriate scientific justifications. 
 
7.5 PROPOSED TIMELINES OF THE ESAC WORKING GROUP 
Item Proposed date/time Action Deliverable 
1 6 May 2016 Teleconference of the Working 
Group 
Agree procedure 
2 11-13 May 2016 Working Group meeting  Draft ESAC WG report and draft 
ESAC opinion 
3 27 May 2016 Circulation of final WG report 
and draft ESAC opinion to ESAC 
Final draft ESAC WG report and 
draft ESAC opinion 
4 9-10 June 2016 Endorsement of WG report and 
ESAC opinion at ESAC42 meeting 
Final ESAC WG report and ESAC 
opinion 
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7.6 QUESTIONS WHICH SHOULD BE ADDRESSED BY THE ESAC WORKING GROUP 
The review should address the questions put forward to ESAC by EURL ECVAM (see section 4.2) and 
the information requirements of the ESAC Working Group Template, where applicable. The ESAC 
Coordinator will provide guidance if needed. 
When preparing the final ESAC WG report to address these questions, the ESAC WG is requested to 
use a pre-defined reporting template. This template (see appendix 1) follows EURL ECVAM's modular 
approach and addresses to which extent the standard information requirements have been 
addressed by the study. The template allows moreover for addressing the issues specific studies 
outlined in section 4.2. The Secretariat will provide guidance if necessary. 
 
 
APPENDIX 1  REPORTING TEMPLATE 
The appended ESAC WG template suggests a structure that is in close agreement with the EURL 
ECVAM information requirements ("modules") for scientific review following validation and allows at 
the same time for the description of the analysis and conclusions concerning more specific questions.  
 
The template can be used for various types of validation studies (e.g. prospective full studies, 
retrospective studies, performance-based studies and prevalidation studies). Depending on the study 
type and the objective of the study, not all sections may be applicable.  
 
However, for reasons of consistency and to clearly identify which information requirements have not 
been sufficiently addressed by a specific study, this template is uniformly used for the evaluation of 
validation studies. 
 
The current template is 
 
TEMPLATE_ESAC-WG_REPORT-v6.doc 
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EURL ECVAM 
SCIENTIFIC 
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COMMITTEE 
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Eye Irritation Test (EIT) 
Title page information 
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ESAC Working Group 
 
Full title: ESAC Working Group on Eye Irritation Test Methods 
 
Abbreviated title:  ESAC WG Eye irritation 
 
The ESAC WG was established in March 2016 by written procedure to assist in the production of an 
ESAC Opinion  by undertaking a peer review of a three laboratory ring trial  of the  SkinEthic™ Human 
Corneal Epithelium (HCE) Eye Irritation Test (EIT), a test method with a wide applicability domain for 
liquids (EITL: Eye Irritation Testing of Liquids) and solids (EITS: Eye Irritation Testing of Solids), 
developed for the prediction of the eye irritation potential of liquid and solid chemicals, specifically 
to distinguish chemicals requiring official classification for eye irritation or serious eye damage 
according to the United Nations Globally Harmonized System of Classification and Labelling of 
Chemicals (UN GHS. UN, 2015) from chemicals not requiring classification (no classification category, 
'non-irritants').   
Following a teleconference on 6 May 2016 the ESAC WG met at EURL-ECVAM 11-13 May 2016 to 
conduct its peer review. 
 
The ESAC WG members appointed by ESAC were: 
 Dr. José Maria Navas (ESAC Member, WG Chair) 
 Dr. Kristina Kejlová (ESAC Member) 
 Prof. Annette Kopp-Schneider (ESAC Member) 
 Dr. Renate Krätke (ESAC Member) 
 Dr. Jon Richmond (ESAC Member) 
 Dr. Dave Allen (Nomination by NICEATM/ICCVAM)  
 Prof. Kyung-Min Lim (Nomination by KoCVAM)  
 
 
ESAC Coordination:  
 Dr. João Barroso (ESAC Coordinator) 
 Dr. Thomas Cole 
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Abbreviations used in the document 
 BLR   Between-laboratory reproducibility 
 CI   Confidence Interval 
 EIT   Eye Irritation Test 
 EITL    Eye Irritation Testing of Liquids  
 EITS    Eye Irritation Testing of Solids 
 EIVS    EURL ECVAM/Cosmetics Europe Eye Irritation Validation Study 
 ESAC   EURL ECVAM Scientific Advisory Committee 
 ESAC WG  ESAC Working Group 
 EU CLP   European Union Regulation on Classification, Labelling and Packaging  
of Substances and Mixtures 
 EURL ECVAM   European Union Reference Laboratory for Alternatives to  
   Animal Testing 
 FDA   (US) Food and Drug Administration 
 GLP   Good Laboratory Practice 
 HCE   Human Corneal Epithelium 
 HPLC/UPLC  High Performance Liquid Chromatography/Ultra Performance Liquid 
Chromatography 
 IATA   Integrated Approach to Testing and Assessment 
 MTT    3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  
 OD   Optical density 
 OECD   Organisation for Economic Co-operation and Development  
 PC   Positive Control 
 RhCE   Reconstructed Human Cornea-like Epithelium 
 RhT   Reconstructed Human Tissue 
 SOP   Standard Operating Procedure 
 TST   Test Submission Template 
 UN GHS  United Nations  Globally Harmonized System for the Classification    
and Labelling of Chemicals. 
 VMG   Validation Management Group 
 WLR   Within-laboratory reproducibility 
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1. Study objective and design 
1.1 Analysis of the clarity of the study objective's definition 
(a) ESAC WG summary of the study objective as outlined in the Test Submission 
The TST and supporting documents provide an adequate summary of the main study objectives:  
 To formally validate the SkinEthicTM HCE test method by a three laboratory ring trial study 
using an appropriate number and range of test chemicals and to obtain data to assess the 
relevance (predictive capacity) and reliability (reproducibility within and between 
laboratories) of the assay. 
 To facilitate its international acceptance in regulatory schemes for hazard assessment of 
liquid and solid chemicals to discriminate chemicals not requiring classification for serious 
eye damage/eye irritancy (No Category) from chemicals requiring classification and labelling 
(Category 1 and Category 2) according to the UN GHS Classification and Labelling of 
Chemicals (UN GHS. UN, 2015) and as implemented by the EU CLP regulation (EU CLP. EC, 
2008a).  
o N.B. The test method was not designed, intended, or evaluated to differentiate 
between GHS Category 1 (irreversible effects) and 2A-B (reversible effects); and 
there is no protocol for the testing of gases and aerosols. 
 To produce evidence to support the test method being incorporated into a tiered testing 
strategy (so-called Bottom-Up/Top-Down testing strategy, Scott L. et al., 2010). The ultimate 
purpose of such a tiered testing strategy being to replace the traditional in vivo Draize eye 
test [Method B.5 of EC Regulation 440/2008 (EC, 2008b) or OECD TG 405 (OECD, 2002)]. 
 
(b) Appraisal of clarity of study objective as outlined in the Test Submission 
The ESAC WG believes that the study objectives were sufficiently clear, and were reflected in the way 
the study was designed, conducted, analysed, and subsequently reported in the TST. 
 
1.2 Quality of the background provided concerning the purpose of the test method  
The TST clearly describes the intended application of the SkinEthicTM HCE test method and suitably 
qualified HPLC/UPLC-spectrophotometry analytical measurement systems as being for regulatory 
testing.  
 
(a) Analysis of the scientific rationale provided in the Test Submission 
The SkinEthicTM HCE test method validation study was designed and conducted to provide evidence of 
whether the test method and EITL and EITS protocols are sufficiently relevant and reliable to identify 
chemicals not requiring classification, i.e. chemicals that are not UN GHS/EU CLP Category 1 (serious 
eye damage) or Category 2 (eye irritant). The results of the study (i.e. prediction of non-classified 
chemicals) are to be considered for use within a testing strategy (Scott et al., 2010).   
The SkinEthicTM  HCE test method TST describes the relevance and scientific rationale of the test 
method partly in terms of other validated and accepted RhT models’ proven ability to measure 
cytotoxicity by the OD-photometric quantification of MTT reduction products (Mosmann, 1983) as a 
reliable surrogate measurement of a range of toxicological endpoints after the controlled exposure 
of an RhT air-tissue interface to solid or liquid test materials. The ESAC WG accepts that in other 
contexts (for example skin irritation) cytotoxicity/cell viability following chemical exposure is a 
recognised surrogate measure for chemically induced in vivo toxicity: with the in vivo cytotoxicity 
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then stimulating  an inflammatory response involving the innate immune system in proportion to the 
degree of cytotoxicity produced by the chemical. 
The TST also provides a scientific rationale and justification in the specific context of eye irritation, 
reasoning that RhCE test system cytotoxicity/tissue viability is a potentially plausible surrogate 
measure of ocular hazards capable of discriminating between UN GHS/EU CLP classified chemicals 
(Category 1 and Category 2) and non-irritants produced by a variety of relevant, known, in vivo 
mechanisms of ocular toxicity.  
While the SkinEthic™ HCE EIT was not developed to account for all mechanisms associated with eye 
irritation, the validation study demonstrated that this RhCE test method is able to correctly predict 
chemicals not requiring classification for serious eye damage/eye irritation independently of the 
types of ocular effects observed in vivo (i.e., corneal, iridal and conjunctival injuries).  
The evidence and arguments advanced in the TST in support of the test method’s performance take 
account of the findings of previous pre-validation studies and other peer reviewed publications. The 
available documentation does not allow an assessment of the test method’s performance with 
mixtures. 
The TST acknowledges that, for the foreseeable future, the in vivo Draize rabbit eye test is unlikely to 
be replaced by a single in vitro test (Eskes et al., 2005), and argues that the intended use of this RhCE 
test method would be within a larger testing strategy designed to replace or reduce animal testing 
for determining chemical-induced eye damage/irritation potential for regulatory purposes (Scott et 
al., 2010).  
The ESAC WG believes the available documentation provides sufficient evidence and reasoned 
arguments in favour of this RhCE test method having the potential to be at least as relevant and 
reliable as the currently validated in vitro methods for the identification of non-irritants [OECD TGs 
437 (OECD, 2013a), 438 (OECD, 2013b), 491 (OECD, 2015a), and 492 (OECD, 2015b)], when combined 
with other alternative methods within future (tiered) testing strategies to replace the Draize eye test 
(Scott et al., 2010). 
It is proposed by Scott et al. (2010) that within such future testing strategies, based on the expected 
ocular toxicity profile of the test chemical, and using one of two tiered testing approaches (Bottom-
Up or Top-Down), the systematic and sequential application of one or more in vitro test methods 
would be used to determine chemically induced eye damage/irritation potential. The full details of 
the appropriate integrated testing strategies and test methods have yet to be defined. 
The TST discusses a known limitation of the currently used OD-photometric endpoint detection 
system - its inability to reliably assess the cytotoxic effects of chemicals, which interfere with the OD-
photometric endpoint measurement of MTT-formazan - and provides a rationale for the use of a 
suitably qualified HPLC/UPLC-spectrophotometry endpoint detection system as an alternative MTT-
formazan endpoint measure. 
 
(b) Analysis of the regulatory rationale provided in the Test Submission 
The TST identifies relevant regulatory requirements. In the view of the ESAC WG, the relevant 
legislation and regulations are appropriately referenced; and the regulatory requirements and the 
role of the RhCE-based methods in the context of the regulatory requirements are adequately 
specified. 
RhCE test methods for eye damage/irritation testing such as the SkinEthicTM HCE test method could 
contribute to a reduction in animal testing by reliably identifying chemicals not requiring 
classification when used within an appropriate non-animal testing strategy (Scott et al., 2010).  
With respect to ocular toxicity, the ESAC WG considers that in view of the high prevalence of non-
classified chemicals (Adriaens et al., 2014) RhCE test methods validated for this purpose and used 
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within a “bottom-up approach” could significantly reduce animal testing by identifying the much 
larger number of chemicals not requiring classification. 
 
1.3 Appraisal of the appropriateness of the study design 
The study and data reported in the TST complies with the principles and criteria set out in the OECD 
Guidance Document on the Validation and International Acceptance of New or Updated Test 
Methods for Hazard Assessment (No. 34, OECD, 2005), and described in the generally accepted 
Modular Approach to validation (Hartung et al., 2004). 
Subject to the comments below (and section 1.4 of this report), the TST and supporting 
documentation tends to confirm compliance with the expected standards for validation study 
organisation, management, and conduct, including: 
 a reasoned scientific basis for the mechanistic relevance of the test method;  
 suitable quality assurance systems for tissue model production and batch release;  
 comprehensive SOPs for method implementation with separate protocols for the testing of 
liquid and solid chemicals;  
 representative and balanced chemical (test item) selection;  
 comprehensive training of and test method transfer to naïve laboratories;  
 clear coordination and suitably defined responsibilities for the ring trial (project management, 
chemicals management, data management); 
 appropriate use of positive and negative controls, criteria and limits for retesting, definition 
of qualified and non-qualified runs, data recording, calculation of WLR, BLR, specificity, 
sensitivity, accuracy;  
 independence of ring trial testing and data statistics analysis; and 
 complete documentation and transparency. 
The SkinEthicTM HCE test method (with separate protocols for testing liquids and solids) was assessed 
for its potential to identify chemicals not requiring classification for serious eye damage/eye irritation 
(UN GHS / EU CLP No Category; “non-irritants”) and their reliable discrimination from all classes of 
classified (categories 1 and 2) chemicals with a view to it forming an initial step of a Bottom-Up 
approach or a later stage of a Top-Down approach (Scott et al., 2010). 
The relevance and reliability of the test method were assessed by a three laboratory ring trial using 
coded test chemicals (N=120): a pre-study statistical power analysis (sample size calculation) having 
calculated within the EIVS study as a minimum requirement N=104 (i.e. 26 classified chemicals and 
26 non-classified chemicals for each of the two protocols).  
The analysis of the test method performance in the TST takes account of the study test results with 
these 120 chemicals, plus data from 125 chemicals used for test method development within L'Oréal, 
and an additional 80 chemicals tested prospectively by L'Oréal.  
The performance of the SkinEthicTM HCE test method (with separate protocols for testing liquids and 
solids) as a potential stand-alone test method for the identification of chemicals not classified for 
serious eye damage/eye irritation in the framework of Bottom-Up test strategies was judged against 
the test method performance acceptance criteria previously derived to evaluate the EIVS study.  
In setting minimum acceptable values for test method performance, the EIVS VMG took into account 
of: 
1. The background and specific objectives of the EIVS validation study; 
2. The requirements of regulatory authorities and industry when testing and classifying 
chemicals for serious eye damage/eye irritation;  
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3. The within test variability inherent in the in vivo Draize eye test data and the manner in 
which these data are currently used for classifying ocular effects according to UN GHS / EU 
CLP;  
4. The performance of other test methods already considered validated for this purpose; 
5. The way in which the in vitro tests are to be used (as one test within a tiered testing 
strategy); and 
6. The desired statistical power of the EIVS validation study. 
The ESAC WG concludes that, subject to specific qualifications set out below (see 1.4), the study 
design was generally appropriate and robust, the acceptance criteria appropriate at the time, and 
that the study findings have provided the evidence and analysis required to satisfy the study 
objectives.  
The ESAC WG believes the TST provides a detailed and reasoned rationale for use of the suitably 
qualified HPLC/UPLC-spectrophotometry analytical method (FDA, 2001; Alépée et al., 2015). 
 
1.4 Appropriateness of the statistical evaluation 
The statistical and data reports annexed to the SkinEthicTM HCE test method TST are detailed and 
informative. The method used for the calculation of the WLR is appropriate.  
The method used for the calculation of predictive capacity using resampling methods (bootstrapping 
of single runs) is also appropriate. 
However, in the view of the WG the most appropriate way of calculating the BLR would have been to 
apply resampling methods that better reflected how test materials would be categorised for 
regulatory purposes – as in practice categorization would be based on a single run not the average of 
three. Nevertheless, in the context of this study it would appear that had this approach been 
followed the reported difference in the performance of the test method would be marginal. 
Non-qualifying test runs were not included in the data used to calculate final BLR or Predictive 
Capacity values.  
No test chemical used for the ring trial was considered incompatible with the method by any of the 
three laboratories, with either the EITS or the EITL protocol. All chemicals were thus included in all of 
the statistical analyses of this test method. 
The results obtained with the EITS and EITL protocols were independently assessed with respect to 
their reproducibility and predictive capacity. 
 
 
2. Collection of existing data 
2.1 Existing data used as reference data 
The TST and annexes provide detailed information on this point. The TST references and relies on an 
extensive collection of information generated before and during the development and pre-validation 
of the test method. 
The essential requirements for chemical selection for the ring trial were toxicological and 
physicochemical properties, and the availability of complete and quality assured supporting in vivo 
data to allow comparative evaluation of the predictive capacity of the RhCE test method as measured 
against in vivo (Draize eye test) reference method.  
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The chemicals selected are all commercially available chemicals and included chemicals: 
 of different physical states; 
 known to induce the full range of in vivo serious eye damage/eye irritation responses based 
on high quality results obtained in the reference in vivo rabbit eye test (Draize, 1944) and the 
UN GHS classification system (i.e., Categories 1, 2A, 2B, or No Category) (UN GHS. UN, 2015);  
 representing  the various known in vivo drivers of classification as reported by Adriaens et al. 
(2014) and Barroso et al. (2016); 
 covering a good and wide representation of organic functional groups;  
 having well-defined chemical structures;  
 known to be coloured chemicals and/or direct MTT reducers; and 
 not associated with prohibitive acquisition and/or disposal costs.  
In total, 120 coded chemicals (60 liquids and 60 solids) were evaluated in three laboratories, with the 
test chemical set having the following qualities: 
 The 120 chemicals were distributed as follows according to the UN GHS classification: 32 
Category 1 (16 liquids and 16 solids), 17 Category 2A (8 liquids and 9 solids), 13 Category 2B 
(8 liquids and 5 solids)  and 58 No Category (28 liquids and 30 solids) chemicals;  
 16 different functional groups: including organic bases, organic acids, neutral organic, 
inorganic bases, soap/surfactant;  
 direct MTT reduction: 11 chemicals identified as MTT reducers and 43 as non MTT reducers 
during Eye Irritation Validation Study (2010); 
 coloured chemicals  (with 2 identified as coloured chemicals during EIVS) and non-coloured 
chemicals;  
 previously used in related validation studies: 55 % (66/120) tested in EIVS. 
75 of the 120 test materials had NOT been in the development or optimisation of the test method. 
The Draize eye test Reference Database (DRD) published in Barroso et al. (2016) was consulted to 
identify the test chemicals used in the validation study. Such database includes data from the 
following sources:   
1. ECETOC database of eye irritation reference chemicals (ECETOC, 1998). 
2. Database from Laboratoire National de la Santé (LNS) (Gautheron et al., 1992). 
3. ZEBET database of eye irritation reference chemicals (Spielmann et al., 1996). 
4. ICCVAM (NICEATM) database of eye irritation reference chemicals.  
5. EURL ECVAM database of chemicals considered for selection in EIVS, including amongst other 
(i) chemicals notified in the EC New Chemicals Database (NCD), (i) chemicals in the EC (DG-
SANCO) Cosmetics Ingredients (CosIng) database, (iii) pesticide actives in the US EPA 
database 
 
2.2 Existing data used as testing data 
Not applicable. 
 
2.3 Search strategy for retrieving existing data 
See Section 2.1 above. 
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2.4 Selection criteria applied to existing data 
See Section 2.1 above. 
 
 
3. Quality aspects relating to data generated during the study 
3.1 Quality assurance systems used when generating the data 
L’Oreal’s R&I laboratory developed the SkinEthic™ HCE EIT test method and was the lead laboratory 
for the ring trial. It is not Good Laboratory Practices (GLP) certified. However, for the purposes of the 
ring trial the following safeguards (Balls et al., 1995) were applied:  
 Qualified personnel, and appropriate facilities, equipment and materials were available  
 Records of the qualifications, training and experience, and a job description for each 
professional and technical individual, were maintained.  
 For each study, an individual with appropriate qualifications, training and experience was 
appointed to be responsible for its overall conduct and for any report issued.  
 Instruments used for the generation of experimental data were inspected regularly, cleaned, 
maintained and calibrated according to manufacturers' instructions. Records of these 
processes were kept, and made available for inspection on request.  
 Reagents were labelled, as appropriate, to indicate their source, identity, concentration and 
stability. The labelling included the preparation and expiry dates, and specific storage 
conditions.  
 All data generated during a study were recorded by the individual(s) responsible. These 
entries were attributable and dated.  
The two  additional laboratories involved in the ring trial were involved in the validation study 
namely CHARLES RIVER LABORATORIES (Edinburgh, United Kingdom) and VITO NV (Flemish Institute 
for Technological Research, Mol, Belgium) are GLP certified and  performed the studies in accordance 
and in compliance with the GLP standards (OECD, 1999).  
 
3.2 Quality check of the generated data prior to analysis 
The study documents state that: 
 
 "...for the statistical analysis, a summary template was designed by the statistician, and the results 
were transferred to this template by the statistician. This summary template was compared with the 
summary templates received from the participating laboratories in order to check that no mistakes 
were made in the transfer of the results. The final conclusions for each chemical were then compared 
to the conclusions of the reports send by the laboratories as an additional check". 
 
 
4. Quality of data used for the purpose of the study (existing and 
newly generated) 
4.1 Overall quality of the evaluated testing data (newly generated or existing) 
The data generated and supplied are of sufficient quality to apply the predetermined acceptance 
criteria and prediction model. 
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4.2 Quality of the reference data for evaluating relevance1 
The quality of data used is considered to be the best available Draize eye test reference data and is 
equivalent to that of data used in previous RhCE validation studies.   
4.3 Sufficiency of the evaluated data in view of the study objective 
The sample size was sufficient to produce appropriately narrow confidence intervals (CIs).  
There is sufficient data for the WG to offer a reasoned opinion about the performance of the test 
method. 
5. Test definition (Module 1)
5.1 Quality and completeness of the overall test definition 
The SkinEthic™ HCE EIT test method is based on RhCE technology; the test material (solid or liquid 
chemicals) is applied directly to the upper surface of the air-tissue interface, and the eye 
damage/irritation potential of the chemical is derived from a prediction model based on percentage 
tissue viability (adjusted against a negative control) as estimated by OD-photometry or HPLC/UPLC-
spectrophotometry of the MTT reduction product formazan.   
The tissue component of the test kit is manufactured by controlled culture of immortalised human 
corneal epithelial cells in a chemically defined medium to produce a multi-layered epithelium similar 
to in vivo corneal epithelium with columnar basal cells, wing cells and squamous cells. The model is 
also characterised by the presence of relevant ultra-structural features (such as intermediate 
filaments, mature hemi-desmosomes and desmosomes) that characterise the corneal epithelium in 
situ. Specific cytokeratins 64kD (K.3) have also been described (Nguyen et al., 2003). 
The test method SOP provides separate protocols for testing liquids and solids. There are four 
essential differences between the two protocols: 
 the length of time that the tissue interface is in contact with the test material (30 minutes
exposure for liquids and 4 hours exposure for solids);
 a requirement for an 18 hours post-exposure incubation phase for solid chemicals;
 the extraction of the MTT formazan product from both the top and bottom surfaces of the
tissue interface in the case of liquids, but only from the bottom surface for solids.
 the prediction models are different (see immediately below).
Following treatment with a test chemical the relative tissue viability is determined against the 
negative control value by the reduction of the vital dye MTT to formazan as measured by OD-
photometry and/or HPLC/UPLC-spectrophotometry. For both Optical Density and HPLC/UPLC-
spectrophotometry endpoints, the result is accepted if: 
 The mean Optical Density (ODNgC) at 570 nm (± 30nm) of the two replicate tissues treated
with negative control is ≥ 1.4 with an upper acceptance limit of ≤2.5.
 The Mean Viability of the two replicate tissues (2 values from each of the two tissues)
treated with positive control, expressed as percentage of the negative control, is ≤ 30 %,
1
 OECD guidance document No. 34 on validation defines relevance as follows: "Description of relationship of the 
test to the effect of interest and whether it is meaningful and useful for a particular purpose. It is the extent to 
which the test correctly measures or predicts the biological effect of interest. Relevance incorporates 
consideration of accuracy (concordance) of a test method." 
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what is much higher than the reported PC mean values (generally < 5 %), so that the 
established threshold (30 %) could be reduced. 
 The TST indicates that when OD is chosen as endpoint the difference of viability between the 
two replicate tissues of a single test chemical should be ≤ 20 in the same run whatever the 
test item (for positive control, negative control, test substances, and all adapted controls). 
The WG notes that this is probably also applicable to the HPLC/UPLC-spectrophotometry 
measurements. 
For the purposes of the Prediction Model tissues treated with chemicals inducing eye irritation or 
serious eye damage (UN GHS/EU CLP Category 2 or Category 1, respectively) were expected to show 
a decrease in tissue viability below a specified threshold in comparison to the negative control. See 
table below. 
 
 
Results are expressed as mean OD, mean percentage viability and difference of viability between the 
two replicate tissues. 
The histological features of the test system, and the use of similar endpoints and endpoint detection 
systems as used within other RhT systems already validated for other toxicological endpoints, make it 
plausible that this test RhCE system may provide insights into the likely eye damage/irritation 
potential of chemicals. 
Although derived from cultured human corneal cells, ESAC WG notes that the cells used have been 
transformed and immortalised. The ESAC WG offers no opinion on whether these cells are inherently 
more biologically relevant in this context than other epithelial cells (e.g. eye irritation RhCE models 
derived from normal untransformed human keratinocytes). 
 
5.2 Quality and completeness of the documentation concerning SOPs and prediction 
models 
The SOPs, including the prediction model, were sufficiently detailed. See section 5.1 above.  
 
 
6. Test materials 
6.1 Sufficiency of the number of evaluated test items in view of the study objective 
The WG believes that the number of test items was sufficient to draw meaningful conclusions with 
respect to the objectives of the study. See 2.1 above. 
 
6.2 Representativeness of the test items with respect to applicability 
The WG believes that the number and nature of the test items selected were adequate to provide 
insights into the applicability domain and the scope and limitations of the test method. See 2.1 above. 
Table 5.1.1. Cell viability values used as threshold for the assessment of the eye irritation or serious 
eye damage (UN GHS/EU CLP) caused by chemicals. 
Cell viability (liquids) Cell viability (solids) 
UN GHS / EU CLP 
classification 
> 60 % > 50 % No Category 
 ≤ 60 %  ≤ 50 % Categories 1 and 2 
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7. Within-laboratory reproducibility (WLR) (Module 2) 
7.1 Assessment of repeatability and reproducibility in the same laboratory 
For liquid test items 
The reliability of the SkinEthic™ HCE EITL protocol was assessed in terms of concordance in 
predictions for three independent experiments.  
The resulting WLR was 95 % (95 %-CI: 86.3 % - 98.3 %) for L’Oréal, 93.3 % (95 %-CI: 84.1 % - 97.4 %) 
for VITO, and 88.3 % (95 %-CI: 77.8 % - 94.2 %) for CRL. In summary, WLR ≥ 88 % between the 
independent runs was observed within the laboratories, exceeding the minimum acceptable value of 
≥ 85 % set by the VMG.  
In addition, the lead laboratory (L’Oréal) prospectively tested 45 additional liquid chemicals in three 
independent experiments. Twenty-two chemicals did not require classification in vivo and 23 
chemicals were classified. Concordant prediction was obtained for 41 of the 45 chemicals, resulting 
in a WLR of 91.1 %, exceeding the minimum values set by the VMG. 
For solid test items  
The reliability of the SkinEthic™ HCE EITS protocol was assessed in terms of concordance in 
predictions for the independent valid runs. The WLR was 96.7 % (95 %-CI: 88.6 % - 99.1 %) for L’Oréal 
and 95.0 % (95 %-CI: 86.3 % - 98.3 %) for VITO and CRL. 
In conclusion, low variation (WLR ≥ 95 %) between the independent runs was observed within the 
laboratories, indicating that the SkinEthic™ HCE EITS protocol is robust. This means that the WLR is 
higher than 95 %, exceeding the minimum value (85 %) set by the EIVS VMG (Barroso et al., 2015; 
EURL ECVAM, 2016). 
The lead laboratory (L’Oréal) prospectively tested 35 additional solid chemicals in three independent 
runs. Twenty-three chemicals did not require classification in vivo and 12 chemicals were classified. A 
concordant prediction was obtained for 34 of the 35 chemicals, resulting in a WLR of 97.1 % 
exceeding the minimum values set by the VMG. 
 
7.2 Conclusion on within-laboratory reproducibility as assessed by the study 
Section 7.1 confirms that the target value set by the EIVS VMG was exceeded by all laboratories in 
the ring trial and further prospective testing undertaken by L'Oréal. 
 
 
8. Transferability (Module 3) 
8.1 Quality of design and analysis of the transfer phase 
The two naïve laboratories participating in the validation of SkinEthic™ HCE received two days 
training by the lead laboratory (L'Oréal).  
Training and proficiency testing was done with coded test chemicals (9 solids, and 9 liquids), these 
included colourants and direct MTT reducers.  
The transfer phase included demonstrating proficiency with the SOP, and completion of the Excel 
spreadsheets. As confirmed by the data, both laboratories demonstrated their proficiency in 
performing the SkinEthic™ HCE EIT method for the Eye Irritation Testing of Liquids (EITL protocol) and 
Solids (EITS protocol). Only one test chemical did not produce concordant results in all cases. 
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Accordingly, the ESAC WG considers that the technicians from the participating laboratories 
demonstrated adequate proficiency in performing the SkinEthic™ HCE and readiness to enter the 
formal validation study. 
 
8.2 Conclusion on transferability to a naïve laboratory / naïve laboratories as assessed by 
the study 
The ESAC WG considers that the technicians from the participating laboratories demonstrated 
adequate proficiency in performing the SkinEthic™ HCE and readiness to enter the formal validation 
study. 
 
 
9. Between-laboratory reproducibility (BLR) (Module 4) 
9.1 Assessment of reproducibility in different laboratories 
For each laboratory, the mean tissue viability and standard deviation over the three independent 
valid runs were calculated to obtain a final classification for each chemical. The evaluation of BLR was 
on the concordance of the final predictions Classified (C) or Not Classified (NC). BLR was reported 
with the Wilson 95 %-CI. 
The minimum acceptable BLR value set by the EIVS VMG was ≥ 80 %. 
Assessment of BLR for Liquids: 
Fifty-six of the 60 liquid chemicals were consistently classified (NC/C) by the three laboratories 
resulting in a BLR of 93.3 % (95 %-CI: 84.1 % - 97.4 %).  
The BLR for the pair-wise comparisons was 93.3 % (56/60 chemicals) for L'Oréal and CRL, 95.0 % 
(57/60 chemicals) for L'Oréal and VITO, and 98.3 % (59/60 chemicals) for CRL and VITO.  
Assessment of BLR for Solids: 
Fifty-eight of the 60 solid chemicals were consistently classified (NC/C) by the three laboratories 
resulting in a BLR of 96.7 % (95 %-CI: 88.6 % - 99.1 %).  
The BLR for the pair-wise comparisons was 96.7 % (58/60 chemicals) for L’Oréal and CRL and for 
L’Oréal and VITO, a 100 % concordance was obtained between CRL and VITO.  
 
9.2 Conclusion on between-laboratory reproducibility as assessed by the study 
The overall BLR for the SkinEthic™ HCE EIT method, based on the result of the ring trial with a 
balanced and representative set of 120 chemicals, was 95.0 % (EITL 93.3 % and EITS 96.7 %). The BLR 
of the SkinEthic™ HCE EIT test method was higher than the defined minimum value of 80 % set by the 
EIVS VMG (Barroso et al., 2015; EURL ECVAM, 2016). 
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In vivo UN GHS Cumulative 
 
L'Oréal 
 
Charles River 
laboratories 
 VITO 
 
I NI  I NI  I NI  I NI 
Classified (n) 283 5  96 0  94 2  93 3 
No Category (n) 77 175  29 55  23 61  25 59 
Total (n) 540  180  180  180 
  
  
 
  
 
  
 
 
Sensitivity (%) 98.3  100  97.9  96.9 
Specificity (%) 69.4  65.5  72.6  70.2 
Accuracy (%) 84.8  83.9  86.1  84.4 
 
10. Predictive capacity and overall relevance (Module 5)  
10.1 Adequacy of the assessment of the predictive capacity in view of the purpose 
The predictive capacity of the assay was evaluated by comparing the prediction results based on the 
individual laboratory results with the existing proposed classification. Two-by-Two contingency tables 
(C versus NC) were constructed and sensitivity, specificity, and accuracy were calculated. 
Bootstrap resampling (10,000 times with sample size = 1) was used to obtain 95 %-CIs for accuracy, 
sensitivity and specificity. The rationale for performing bootstrap resampling with size n=1 was the 
fact that in reality a chemical will be tested and classified only once.  
Sensitivity, specificity, and accuracy were calculated on 10,000 simulated sets of 120 chemicals (60 
liquids and 60 solids), based on observed predictions (9 predictions per chemical). Random sampling 
with sample size n=1 was performed per chemical (with a pool of 9 predictions, based on 3 
independent runs for each chemical at each of the 3 laboratories) for the set of 60 liquids or 60 solid 
chemicals.  
Accuracy, sensitivity and specificity were calculated for each of the 10,000 resampling sets. The mean 
of the bootstrap sample and 95 %-CI applying the percentile method was calculated for the three 
performance parameters. 
Reference data were use appropriately and the resulting data sets were adequate to assess test 
method performance. 
Assessment of predictive capacity for liquid chemicals: 
Predictive capacity was calculated for each laboratory and for the cumulative results of the three 
laboratories using the cut-off of 60 % viability to distinguish between chemicals not requiring 
classification for serious eye damage/eye irritancy (No Cat) from chemicals requiring classification 
and labelling (Cat 1 and Cat 2) according to UN GHS (UN, 2015) (Table 10.1.1 below). 
 
Table 10.1.1. Predictive capacity for the set of 60 liquid chemicals based on individual laboratory 
predictions: overall and for each laboratory. 
 
 
 
 
 
The predictive capacity was also determined for the extended dataset (60 liquid chemicals of the 
multicenter study and 45 additional liquid chemicals) tested by the lead laboratory. This resulted in 
an overall accuracy of 83.5 % with 100 % sensitivity and 65.3 % specificity for L’Oréal only. 
The bootstrap resampling yielded a sensitivity of 98.2 % (95 %-CI: 93.8 % - 100 %), a specificity of 
69.4 % (95 %-CI:  60.7 % - 75.0 %), and an accuracy of 84.8 % (95 %-CI: 80.8 % - 88.3 %). 
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Assessment of predictive capacity for solid chemicals: 
The predictive capacity was calculated for each laboratory and for the cumulative results of the three 
laboratories using the cut-off of 50 % viability to distinguish NC (No Cat) from chemicals requiring 
classification and labelling (Cat 1 and Cat 2) according to UN GHS (Table 10.1.2). The calculations 
were based on the individual predictions derived from the qualified tests for each chemical in each 
laboratory. The three laboratories obtained a sensitivity of 92.2 %. The specificity varied between 
75.3 % (VITO), 75.6 % (L’Oréal), and 78.9 % (CRL). An accuracy of 83.9 %, 85.6 %, and 83.3 % was 
obtained by L’Oréal, CRL, and VITO, respectively (See table 10.1.2 below) 
 
Table 10.1.2. Predictive capacity for the set of 60 solid chemicals based on individual laboratory 
predictions: overall and for each laboratory 
In vivo UN GHS Cumulative 
 
L'Oréal 
 
CRL  VITO 
 
C NC  C NC  C NC  C NC 
Classified (n) 249 21  83 7  83 7  83 7 
No Category (n) 63 206  22 68  19 71  22 67 
Total (n) 539  180  180  179 a 
  
  
 
  
 
  
 
 
Sensitivity (%) 92.2  92.2  92.2  92.2 
Specificity (%) 76.6  75.6  78.9  75.3 
Accuracy (%) 84.4  83.9  85.6  83.3 
 
 
a For chemical No. 2 only two valid runs were obtained over the five runs 
 
The predictive capacity was also determined for the extended dataset (60 solid chemicals of the 
multicenter study and 35 additional solid chemicals) tested by the lead laboratory. This resulted in an 
overall accuracy of 80.7 % with 89.7 % sensitivity and 73.6 % specificity for L’Oréal only. 
The bootstrap resampling yielded a sensitivity of 91.9 % (95 %-CI: 90.0 % - 93.3 %), a specificity of 
76.6 % (95 %-CI:  73.3 % - 80.0 %), and an accuracy of 84.3 % (95 %-CI: 81.7 % - 86.7 %). 
All of the reported values exceeded the minimum acceptable values as set by the VMG which were a 
sensitivity of at least 90 %, a specificity of at least 60 %, and an accuracy of at least 75 %. None of the 
Category 1 chemicals were under-predicted in the majority of the runs across all laboratories.  
However the working group notes that false negative results were obtained in a total of 2 
independent runs at the same laboratory for 1 chemical ( [3-(2-Aminoethylamino)propyl]- 
trimethoxysilane, CASRN 1760-24-3, classified Category 1 in the Draize eye test based on persistent 
conjunctival and corneal effects on day 21 in the majority of the animals). Therefore this chemical 
was classified by this laboratory as a No Category. Having investigated this anomaly the test 
developer reported that due to storage problems at this laboratory there was crystal formation for 
this chemical during storage with the first run (viability: 25.1 %) giving the correct classification. This 
first run was performed in the beginning of the experimental phase whereas the second and third 
runs, which gave the misclassification, were performed at the end of the experimental phase (more 
than 60 days later). The effect of storage conditions on the stability of this chemical ([3-(2-
Aminoethylamino)propyl]trimethoxysilane) was evaluated after the validation study. Indeed, 
confirmatory work has shown that the tissue viability increased when the container of the chemical 
was not closed properly. After 14 and 30 days of storage with half open or open lid, mean viability 
increased above 50 % (51.5 % to 66.3 %). In the two other laboratories, the independent runs for the 
[3-(2-Aminoethylamino)propyl]-trimethoxysilane were performed within a period of less than 30 
days. The WG believes that had this chemical been properly stored then an appropriate classification 
would have been achieved. 
In addition, another chemical (Tetraethylene glycol diacrylate, CASRN 17831-71-9, classified as 
Category 1 based on iritis that resulted in severe but delayed corneal opacity in the Draize eye test) 
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was misclassified in 1 run at 1 laboratory – but in this case the overall classification by that laboratory 
on the basis of three qualified run sequences was irritant in the in vitro assay. 
 
10.2 Overall relevance (biological relevance and accuracy) of the test method in view of 
the purpose 
See section 10.1. The WG believes that the overall relevance of the test method has been 
satisfactorily demonstrated with a view to it being considered for regulatory use within an integrated 
approach to testing and assessment (IATA) for the prediction of eye damage/irritation potential of 
chemicals within its applicability domain. 
 
 
11. Applicability domain (Module 6)  
11.1 Appropriateness of study design to conclude on applicability domain, limitations and 
exclusions 
The validation study was undertaken with a large number of liquid and solid test materials 
representing a broad range of chemical classes (see 2.1) and a full range of ocular reactivity. However, 
there is limited information on test method performance with mixtures, and chemicals in the form of 
gases and aerosols were not assessed in a validation study.  
 
11.2 Quality of the description of applicability domain, limitations, exclusions 
As indicated in section 11.1, gases and aerosols were not considered in the validation study.  
SkinEthic™ HCE EIT test method is not intended to differentiate between UN GHS Category 1 (serious 
eye damage) and UN GHS Category 2 (eye irritation). This differentiation will need to be addressed by 
another tier of a testing strategy (Scott et al., 2010). A chemical that is identified as requiring 
classification for eye irritation/serious eye damage with SkinEthic™ HCE EIT will thus require 
additional testing (in vitro and/or in vivo) to establish a definitive classification, using e.g., OECD TG 
437 (OECD, 2013a), 438 (OECD, 2013b), 460 (OECD, 2012) or 491 (OECD, 2015a). 
 
 
12. Performance standards (Module 7)  
Performance standards were not addressed by TST but are already available at OECD based on the 
similar method EpiOcularTM EIT (OECD, 2015c). 
 
12.1 Adequacy of the proposed Essential Test Method Components 
Not applicable – see immediately above. 
 
12.2 Adequacy of the Reference Chemicals 
Not applicable – see immediately above. 
 
12.3 Adequacy of proposed performance target values 
Not applicable – see immediately above. 
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13. Readiness for standardised use 
13.1 Assessment of the readiness for regulatory purposes 
The WG believes that the overall relevance and reliability of the test method has been satisfactorily 
demonstrated with a view to it being considered for regulatory use in a tiered assessment strategy. 
The test could be applied as a first step in Bottom-Up discrimination of 'non-irritants' (GHS No 
Category) or as a confirmatory last step in a Top-Down approach, where the priority is to first 
discriminate chemicals inducing serious eye damage (GHS Category 1). However, the method is not 
intended to differentiate Category 1 from Category 2 on its own. 
 
13.2 Assessment of the readiness for other uses  
The study findings justify the SkinEthic™ HCE EIT method being considered as a means of identifying 
chemicals do not cause eye damage/irritation in non-regulatory contexts. 
 
13.3 Critical aspects impacting on standardised use 
The TST indicates that two training days are required for a naïve laboratory. 
All HPLC/UPLC-spectrophotometry systems have to be suitably qualified (FDA, 2001; Alépée et al., 
2015). 
 
13.4 Gap analysis 
1. The SkinEthic™ HCE EIT test method liquid and solid chemical protocols could form 
components of future integrated approaches to testing and assessment (IATA) for 
determining the eye damage/irritation potential of chemicals (Scott et al., 2010). The other 
components of such a testing strategy and the precise role of these RhCE test methods have 
yet to be formally defined. 
2. As mentioned above the ESAC WG notes that there is limited information on the 
performance of this test method with chemical mixtures and no information about gases and 
aerosols.  
3. The WG acknowledges that including a wide range of chemical mixtures in validation studies 
currently raises several problems, e.g. availability of in vivo data, selection of test mixtures, 
and continuity of supply. However, most of the chemicals which have to be classified are 
mixtures and there is a need to confirm that in vitro methods can be used for the 
classification of chemical mixtures. The ESAC WG recommends the inclusion of a broader 
range of chemical mixtures in future validation studies, and proposes consideration of the 
use of reference data available for the classification of mixtures, using the additivity 
approach recommended by the UN GHS (UN, 2015) as well as the CLP (EC, 2008a), and/or the 
use of mixtures already assessed and identified as Cat.1, Cat.2, or No Cat. 
4. While the SkinEthic™ HCE EIT was not developed to account for all mechanisms associated 
with eye irritation, the validation study demonstrated that this RhCE test method is able to 
correctly predict chemicals not requiring classification for serious eye damage/eye irritation 
independently of the types of ocular effects observed in vivo (i.e., corneal, iridal and 
conjunctival injuries). 
5. The available documentation does not allow an assessment of the test method’s 
performance with mixtures. 
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6. For RhCE test methods that use cytotoxicity as a surrogate measure of eye damage/irritation 
potential it is plausible that related test methods could be developed to allow histological 
and other evaluation of the tissue damage to provide additional insights into the mechanism 
of injury.   
7. There is a lack of information in the TST about inter-laboratory reproducibility of HPLC/UPLC-
spectrophotometry analytical method. However, this has been demonstrated for the 
HPLC/UPLC-spectrophotometry measurement of formazan in isopropanol extracts obtained 
from other RhTs (ESAC, 2014; Alépée et al., 2015). 
 
 
14. Other considerations 
The ESAC WG notes that due to the variability of individual animal responses within the in vivo 
Draize eye test there is ≥ 12 % probability, if chemicals are retested, of chemicals currently 
classified as UN GHS Category 2 by the in vivo test being identified as UN GHS No Category 
(Adriaens et al., 2014). As in vivo Draize eye test data served as reference data for chemical 
selection and Predictive Capacity within validation studies, the reported performance of the in 
vivo test should be borne in mind when evaluating the reported performance, and validity, of 
alternative methods and testing strategies for detecting chemically induced eye 
damage/irritation.  
The reported PC mean values (generally < 5 %) are significantly lower than the 30 % acceptance 
threshold set out in the SOP. The PC was also generally reproducible with maximum viabilities 
unequivocally acceptable. The WG suggests that consideration be given to reducing the PC 
acceptance criterion threshold. 
 
 
15. Conclusions on the study 
15.1 ESAC WG summary of the results and conclusions of the study 
1. The SkinEthic™ HCE EIT test method study was generally well designed and conducted, and 
the TST provides analysis and insights that allows the WG to offer an informed opinion about 
the performance of the test method. 
2. The ESAC WG considers that the SkinEthic™ HCE EIT test method liquid and solid chemical 
protocols are scientifically valid (reproducible and accurate) in the context of identifying 
chemicals not requiring classification for serious eye damage/eye irritation under UN GHS.   
3. The ESAC WG considers that although a wide range of chemical types, chemical classes, 
molecular weights, LogP, chemical structures, etc., were tested, no clear additional 
limitations regarding applicability could be identified beyond those identified in the TST.  
4. The ESAC WG has noted that currently there is only a limited range of chemical mixtures 
available for use as test chemicals within eye damage/irritation validation studies, and would 
like to see more data presented with respect to the test method performance in the case of 
chemical mixtures requiring the classification for eye damage/irritation potential. 
5. For coloured chemicals interfering too strongly with the MTT-reduction assay an alternative 
endpoint detection system should be used (e.g., suitably qualified HPLC/UPLC-
spectrophotometry). The ESAC WG agrees, and believes that qualified HPLC/UPLC-
spectrophotometry endpoint measurement system described in the TST is suitable for this 
purpose. 
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15.2 Extent to which study conclusions are justified by the study results alone 
All of the ESAC WG conclusions given above can be derived and argued or justified from the TST and 
supporting documents. 
 
15.3 Extent to which conclusions are plausible in the context of existing information 
In reaching its conclusions the ESAC WG has also taken account of the larger body of information and 
knowledge set out in the technical annexes supplied and the references cited in the study documents. 
It is on consideration of both the study findings, and that larger body of knowledge of information, 
that the ESAC WG established and confirmed the plausibility of the conclusions set out above.  
 
 
16. Recommendations 
16.1 General recommendations 
The ESAC WG believes that the overall relevance and reliability of the SkinEthic™ HCE EIT has been 
satisfactorily demonstrated with a view to it being considered for regulatory use in a tiered 
assessment strategy. The test method could be applied as a first step in Bottom-Up discrimination of 
'non-irritants' (GHS No Category) or as a confirmatory last step in a Top-Down approach, where the 
priority is to first discriminate chemicals inducing serious eye damage (GHS Category 1). However, 
the method is not intended to differentiate Category 1 from Category 2 on its own. 
The validation study results tend to confirm the findings of the EIVS study that suitably qualified 
HPLC/UPLC-spectrophotometry analytical systems can be used to quantify precipitated MTT-
formazan as an alternative endpoint detection system in particular for highly coloured chemicals 
interfering with the conventional endpoint measurement of MTT-formazan by OD-photometry. 
 
16.2 Specific recommendations (e.g. concerning improvement of SOPs) 
The ESAC WG offers the following additional recommendations for consideration. 
While the SkinEthic™ HCE EIT was not developed to account for all mechanisms associated with eye 
irritation, the validation study demonstrated that this RhCE test method is able to correctly predict 
chemicals not requiring classification for serious eye damage/eye irritation independently of the 
types of ocular effects observed in vivo (i.e., corneal, iridal and conjunctival injuries). 
There may be an option to harmonise the protocols for liquid and solid chemicals in relation to the 
extraction procedures of formazan, if categorisation of chemicals based on extraction from only 
under-surface of the tissue interface meets the performance of the different extraction procedures 
given in the SOP for liquid and solid chemicals. 
The ESAC WG recommends insights into test performance with chemical mixtures be obtained by 
testing mixtures based on their current classification, or based on the known properties of their 
components. 
The ESAC WG believes that potential problems with the reliability of historical Draize eye test data 
must also be taken into account when evaluating the predictive capacity of alternative test methods 
and testing strategies. 
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